Bristol Myers Squibb Co. Stock Falls Thursday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slipped 0.47% to $71.60 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.34% to 3,983.17 and the Dow Jones Industrial Average rising 0.64% to 34,189.97. The stock's fall snapped a two-day winning streak. Bristol Myers Squibb Co. closed $9.84 below its 52-week high ($81.44), which the company reached on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.50% to $174.00, Pfizer Inc. (PFE) rose 0.55% to $47.71, and Abbott Laboratories (ABT) fell 1.14% to $111.36. Trading volume (6.8 M) remained 2.4 million below its 50-day average volume of 9.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 12, 2023.
(END) Dow Jones Newswires
January 12, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.